Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae

Microbial Pathogenesis

Volumn 36, Issue 6, 2004, Pages 303-310

  Kerr, Alison R ^a   Wei, Xiao Qing ^a   Andrew, Peter W ^b   Mitchell, Tim J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cytokines; Gram positive sepsis; Nitric oxide; Streptococcus pneumoniae

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; TUMOR NECROSIS FACTOR;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD FLOW; FEMALE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; SURVIVAL; WILD TYPE;

ANIMALS; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; INTERFERON TYPE II; INTERLEUKIN-6; LUNG; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PROTEINS; SEPSIS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 2142830997     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2004.02.001     Document Type: Article

References (31)

1. Kemper C.A., Deresinki S.C. The immunology of pneumococcal pneumonia. Chmel H., Bendinelli M., Friedman H. Pulmonary infections and immunity. 1994;29-49 Plenum Press, New York
2. White R.T.M. Pneumococcal vaccine. Thorax. 43:1988;345-348
3. Goldsmith C.E., Moore J.E., Murphy P.G. Pneumococcal resistance in the UK. J Antimicrob Chemother. 40:1997;11-18
4. Tsai W.C., Strieter R.M., Zisman D.A., et al. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect Immun. 65:1997;1870-1875
5. Bergeron Y., Ouellet N., Deslauriers A.-M., Simard M., Olivier M., Bergeron M.G. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun. 66:1998;912-922
6. Ochoa J., Udekwu A., Billar T., et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 214:1991;621-626
7. Fang F.C. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 99:1997;2818-2825
8. Igietseme J.U., Perry L.L., Ananaba G.A., et al. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun. 66:1998;1282-1286
9. Nozaki Y., Hasegawa Y., Ichiyama S., Nakashima I., Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 65:1997;3644-3647
10. Bergeron Y., Ouellet N., Simard M., Olivier M., Bergeron M.G. Immumomodulation of pneumococcal pulmonary infection with NG-monomethyl-L- arginine. Antimicrob Agents Chemother. 43:1999;2283-2290
11. Wei X.-Q., Charles I.G., Smith A. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411
12. Niedbala W., Wei X.-Q., Piedrafita D., Xu D., Liew F.Y. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol. 29:1999;2498-2505
13. MacMicking J.D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650
14. Kerr A.R., Irvine J.J., Search J.J., et al. The role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun. 70:2002;1547-1557
15. Rubins J.B., Charboneau D., Paton J.C., Mitchell T.J., Andrew P.W., Janoff E.N. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest. 95:1995;142-150
16. Starnes H.F.J., Pearce M.K., Tewari A., Yim J.H., Zou J.-C., Abrams J.S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumour necrosis factor-α challenge in mice. J Immunol. 145:1990;4185-4191
17. Kaplan S.S., Lancaster J.R.J., Basford R.E., Simmons R.L. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun. 64:1996;69-76
18. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526
19. Perry F.E., Elson C.J., Greenham L.W., Catterall J.R. Interference with the oxidative response of neutrophils by Streptococcus pneumoniae. Thorax. 48:1993;364-369
20. Eigler A., Sinha B., Endres S. Nitric oxide-releasing agents enhance cytokine induced tumor necrosis factor synthesis in human mononuclear cells. Biochem Biophys Res Commun. 196:1993;494-501
21. Stephens K.E., Shizaka A., Larrick J.W., Raffin T.A. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis. 137:1987;1364-1370
22. Guidot D.M., Hybertson B.M., Kitlowski R.P., Repine J.E., Inhaled N.O. prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol. 271:1996;L225-L229
23. Dehoux M.S., Boutten A., Ostinelli J., et al. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 150:1994;710-716
24. Wara D.W. Host defense against Streptococcus pneumoniae: the role of the spleen. Rev Infect Dis. 3:1981;299-309
25. Saetre T., Höiby E.A., Aspelin T., Lermark G., Egeland T., Lyberg T. Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Crit Care Med. 29:2000;2697-2706
26. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389
27. Sriskandan S., Cohen J. The pathogenesis of septic shock. J Infect. 30:1995;201-206
28. Alexander J.E., Lock R.A., Peeters C.C.A.M., et al. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun. 62:1994;5683-5688
29. Kadioglu A., Gingles N.A., Grattan K., Kerr A., Mitchell T.J., Andrew P.W. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun. 68:2000;492-501
30. van der Poll T., Marchant A., Keogh C.V., Goldman M., Lowry S.F. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 174:1996;994-1000
31. Rockett K.A., Awburn M.M., Rockett E.J., Cowden W.B., Clark I.A. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:1994;243-249